Treatments · Entity Annotation Prototype (beta)

3articles mentioning treatments

6treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: PD-1 immunotherapy ×

PD-1 immunotherapy

This treatment is selected. Its supporting articles are shown below.

PD-1 immunotherapy3

Articles mentioning PD-1 immunotherapy

3 articles · page 1 of 1

455 Treg-associated ICOS as a possible biomarker for PD-1 therapy resistance in melanoma patients

jitc · abstract · 2025-11-04 · 4 matching annotations

91.3%

PD-1 immunotherapy combination immunotherapy immunotherapy University of California Irvine melanoma nivolumab Chao Family Comprehensive Cancer Center ipilimumab αPD-1

…Background PD-1 immunotherapy revolutionized cancer treatment since its approval in 2014 but …

1122 Identifying critical features of tumor responsiveness to PD-1 immunotherapy using mathematical and biological models

jitc · abstract · 2025-11-04 · 1 matching annotations

82.1%

PD-1 blockade PD-1 immunotherapy αPD-1 immunotherapy nivolumab University of California Irvine advanced melanoma ipilimumab Chao Family Comprehensive Cancer Center melanoma Melanoma-intrinsic+1 more

…Background Only 23% of advanced melanoma patients treated with PD-1 blockade have a ten-year progression free survival, 1 and it remains unk…

1140 Wild-derived microbiota enhances the function of intratumor CD8+ T cells

jitc · abstract · 2025-11-04 · 1 matching annotations

89.9%

PD-1 immunotherapy University of California Irvine nivolumab ipilimumab New England Journal of Medicine melanoma Wildling mice Institutional Animal Care and Use Committee

… intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell. 2024;42(6):1051–1066.e7.Ethics Approval This stud…